SA PRO
Free Account
Themes
ProKidney Corp.PROKNASDAQ
Loading
OverviewIntelligenceChartsNews

Analyst Sentiment

Analysts lean bullish — 71% recommend buying.

Consensus Rating
Buy
7 analysts·Limited coverage
71%
Rating Distribution
Strong Buy
00%
Buy
571%
Hold
114%
Sell
114%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 90% higher.

Bear Case
$3.00
+22%
Consensus
$4.67
+90%
Bull Case
$6.00
+144%
Price Range7 analysts
Low
Consensus
High
$3.00
$6.00
Current Target
Current Price
$2.46
Upside to Target
$2.21

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Sep 4, 2024Bank of America Securities
ProKidney price target lowered to $3 from $4 at BofA
Target:$3.00
+25.0%from $2.40
Sep 3, 2024BTIG
BTIG Reiterates Buy Rating on ProKidney Corp. (PROK)
Target:$5.00
+108.3%from $2.40
Jun 10, 2024Jefferies
ProKidney Corp. (PROK) PT Lowered to $6 at Jefferies
Target:$6.00
+98.7%from $3.02
May 28, 2024BTIG
BTIG Reiterates Buy Rating on ProKidney Corp. (PROK)
Target:$6.00
+61.7%from $3.71
Dec 21, 2022Jefferies
Jefferies Initiates Coverage On ProKidney with Buy Rating, Announces Price Target of $15
Target:$15.00
+105.5%from $7.30

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance